Diagnos Inc. (ADK.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 307 | 252 | 46 | 138 | 418 |
| Marketable Securities | 31 | 231 | 51 | 556 | 801 |
| Receivables | 213 | 173 | 333 | 298 | 416 |
| TOTAL | $593 | $712 | $490 | $1,093 | $1,703 |
| Non-Current Assets | |||||
| PPE Net | 69 | 80 | 76 | 104 | 146 |
| Investments And Advances | 0 | 0 | 0 | 10 | 6 |
| TOTAL | $69 | $80 | $76 | $114 | $152 |
| Total Assets | $662 | $792 | $567 | $1,207 | $1,854 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 695 | 238 | 28 | 1,670 | 1,636 |
| Accounts payable and accrued liabilities | 132 | 122 | 231 | 143 | 213 |
| Accrued Expenses | 116 | 136 | 104 | 575 | 398 |
| TOTAL | $1,013 | $585 | $414 | $2,481 | $2,393 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 138 | 135 | 3,777 | 3,769 |
| Deferred Revenues | 7 | 27 | 1 | 4 | 67 |
| TOTAL | $19 | $169 | $157 | $3,809 | $3,810 |
| Total Liabilities | $1,032 | $754 | $570 | $6,290 | $6,202 |
| Shareholders' Equity | |||||
| Common Shares | 30,278 | 30,278 | 29,745 | 23,698 | 23,284 |
| Retained earnings | -39,069 | -38,502 | -37,955 | -36,950 | -36,203 |
| Other shareholders' equity | 8,421 | 8,261 | 8,207 | 8,169 | 8,571 |
| TOTAL | $-370 | $38 | $-4 | $-5,083 | $-4,348 |
| Total Liabilities And Equity | $662 | $792 | $567 | $1,207 | $1,854 |